NODAL MARGINAL ZONE B-CELL LYMPHOMA
Clinical trials for NODAL MARGINAL ZONE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NODAL MARGINAL ZONE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for NODAL MARGINAL ZONE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for aggressive lymphoma: drug combo shows promise in early trial
Disease control CompletedThis study tested a combination of the drug lenalidomide with standard chemotherapy (called DA-EPOCH-R) in 55 people with a fast-growing type of B-cell lymphoma linked to the MYC gene. The goal was to find the safest dose and see if the combo helps keep the cancer from growing or…
Matched conditions: NODAL MARGINAL ZONE B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
New Two-Step transplant shows promise for blood cancer patients
Disease control CompletedThis study tested a two-step stem cell transplant for people with blood cancers like leukemia and lymphoma. The approach uses chemotherapy and radiation before donor stem cells are given, followed by drugs to prevent graft-versus-host disease. The goal was to control the cancer a…
Matched conditions: NODAL MARGINAL ZONE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC